Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial

BACKGROUND: Iron-deficiency anemia is common in inflammatory bowel disease, requiring oral or intravenous iron replacement therapy. Treatment with standard oral irons is limited by poor absorption and gastrointestinal toxicity. Ferric maltol is an oral iron designed for improved absorption and toler...

Descripción completa

Detalles Bibliográficos
Autores principales: Howaldt, Stefanie, Domènech, Eugeni, Martinez, Nicholas, Schmidt, Carsten, Bokemeyer, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889281/
https://www.ncbi.nlm.nih.gov/pubmed/33988236
http://dx.doi.org/10.1093/ibd/izab073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889281/
https://www.ncbi.nlm.nih.gov/pubmed/33988236
http://dx.doi.org/10.1093/ibd/izab073

Ejemplares similares